Lower ARV prices negotiated in Mexico
This article was originally published in Scrip
Executive Summary
Several pharmaceutical companies have reduced the prices of their antiretrovirals in Mexico following negotiations with the government there, the Mexican health ministry has said. Thanks to the reductions, the ministry estimates that it will save Ps310 million ($30.6 million) annually.
You may also be interested in...
EU Pharmaceutical Strategy Roadmap Seen As Weak On Innovation
Pharmaceutical industry groups say the European Commission’s Pharmaceutical Strategy Roadmap lacks detail on delivering a faster regulatory process and encouraging competitiveness.
Australia’s TGA Seeks Feedback on Data Matrix Code Labeling
The Australian Therapeutic Goods Administration is consulting on a draft standard for data matrix codes on the labels of certain medicines.
EMA Scientific Advice Demand Up But Not For Orphan Drugs
The European Medicines Agency received more requests for scientific advice in 2019 than it did in 2018. Meanwhile, requests for advice in other areas has fallen.
Need a specific report? 1000+ reports available
Buy Reports